29.53
price down icon1.57%   -0.47
pre-market  Pre-market:  29.98   0.45   +1.52%
loading
Rapt Therapeutics Inc stock is traded at $29.53, with a volume of 554.71K. It is down -1.57% in the last 24 hours and up +23.30% over the past month. RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
See More
Previous Close:
$30.00
Open:
$29.75
24h Volume:
554.71K
Relative Volume:
1.84
Market Cap:
$488.36M
Revenue:
$3.25M
Net Income/Loss:
$-116.80M
P/E Ratio:
-9.682
EPS:
-3.05
Net Cash Flow:
$-98.17M
1W Performance:
+0.65%
1M Performance:
+23.30%
6M Performance:
+322.15%
1Y Performance:
+108.55%
1-Day Range:
Value
$28.86
$30.00
1-Week Range:
Value
$25.50
$42.39
52-Week Range:
Value
$5.6652
$42.39

Rapt Therapeutics Inc Stock (RAPT) Company Profile

Name
Name
Rapt Therapeutics Inc
Name
Phone
(650) 489-9000
Name
Address
561 ECCLES AVENUE, SOUTH SAN FRANCISCO, CA
Name
Employee
61
Name
Twitter
Name
Next Earnings Date
2024-11-11
Name
Latest SEC Filings
Name
RAPT's Discussions on Twitter

Compare RAPT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
RAPT
Rapt Therapeutics Inc
29.53 496.13M 3.25M -116.80M -98.17M -3.05
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
421.39 108.36B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
463.43 60.82B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
577.95 61.02B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
817.32 50.01B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
310.81 34.05B 4.56B -176.77M 225.30M -1.7177

Rapt Therapeutics Inc Stock (RAPT) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-20-25 Upgrade JP Morgan Neutral → Overweight
Oct-13-25 Initiated Barclays Overweight
Sep-26-25 Upgrade Leerink Partners Market Perform → Outperform
Jul-30-25 Upgrade JP Morgan Underweight → Neutral
May-22-25 Resumed H.C. Wainwright Buy
Dec-26-24 Upgrade H.C. Wainwright Neutral → Buy
Nov-13-24 Downgrade Stifel Buy → Hold
Nov-11-24 Downgrade JP Morgan Neutral → Underweight
Nov-11-24 Downgrade Piper Sandler Overweight → Neutral
May-14-24 Downgrade Wolfe Research Outperform → Peer Perform
May-10-24 Downgrade Barclays Overweight → Equal Weight
May-10-24 Downgrade Guggenheim Buy → Neutral
Feb-22-24 Downgrade UBS Buy → Neutral
Feb-21-24 Downgrade H.C. Wainwright Buy → Neutral
Feb-21-24 Downgrade JP Morgan Overweight → Neutral
Feb-21-24 Downgrade Leerink Partners Outperform → Market Perform
Feb-20-24 Downgrade Cantor Fitzgerald Overweight → Neutral
Feb-16-24 Initiated Evercore ISI Outperform
Feb-15-24 Initiated Wolfe Research Outperform
Sep-14-23 Initiated Berenberg Buy
Aug-09-23 Initiated Stifel Buy
Jun-15-23 Initiated Barclays Overweight
Jan-04-23 Initiated Guggenheim Buy
Dec-01-22 Initiated Goldman Buy
Sep-21-22 Initiated CapitalOne Overweight
May-24-22 Resumed Cantor Fitzgerald Overweight
Dec-09-21 Initiated JP Morgan Overweight
Aug-12-21 Initiated SVB Leerink Outperform
Jun-21-21 Initiated Piper Sandler Overweight
Jun-01-20 Initiated H.C. Wainwright Buy
May-19-20 Initiated Cantor Fitzgerald Overweight
Apr-13-20 Initiated ROTH Capital Buy
Nov-25-19 Initiated BMO Capital Markets Outperform
Nov-25-19 Initiated UBS Buy
Nov-25-19 Initiated Wells Fargo Outperform
View All

Rapt Therapeutics Inc Stock (RAPT) Latest News

pulisher
04:37 AM

Analyzing RAPT Therapeutics Inc. with multi timeframe chartsQuarterly Earnings Report & Verified Trade Idea Suggestions - newser.com

04:37 AM
pulisher
04:29 AM

Why retail investors favor RAPT Therapeutics Inc. stockIPO Watch & Weekly Watchlist for Hot Stocks - newser.com

04:29 AM
pulisher
04:00 AM

Tick level data insight on RAPT Therapeutics Inc. volatilityWeekly Earnings Recap & AI Driven Stock Price Forecasts - newser.com

04:00 AM
pulisher
03:59 AM

Risk adjusted return profile for RAPT Therapeutics Inc. analyzedDividend Hike & AI Enhanced Trade Execution Alerts - newser.com

03:59 AM
pulisher
03:57 AM

Published on: 2025-10-27 02:57:37 - newser.com

03:57 AM
pulisher
03:53 AM

Can RAPT Therapeutics Inc. recover in the next quarterPortfolio Risk Summary & Comprehensive Market Scan Reports - newser.com

03:53 AM
pulisher
03:20 AM

Is RAPT Therapeutics Inc. stock a buy for dividend growthJuly 2025 Recap & Fast Gain Swing Alerts - newser.com

03:20 AM
pulisher
02:15 AM

What indicators show strength in RAPT Therapeutics Inc.Trade Performance Summary & Consistent Profit Focused Trading Strategies - newser.com

02:15 AM
pulisher
01:59 AM

Published on: 2025-10-27 00:59:41 - newser.com

01:59 AM
pulisher
12:33 PM

Does RAPT Therapeutics Inc. (0RA) stock trade below intrinsic value2025 Analyst Calls & Momentum Based Trading Signals - newser.com

12:33 PM
pulisher
12:23 PM

Published on: 2025-10-26 23:23:14 - newser.com

12:23 PM
pulisher
Oct 26, 2025

Is RAPT Therapeutics Inc. stock reversal real or fakeDay Trade & Reliable Breakout Stock Forecasts - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Published on: 2025-10-26 21:27:10 - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Published on: 2025-10-26 20:42:00 - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Why RAPT Therapeutics Inc. (0RA) stock could break out in 2025Quarterly Earnings Report & Technical Entry and Exit Alerts - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Is RAPT Therapeutics Inc. (0RA) stock dividend growth reliableJuly 2025 Closing Moves & Verified Momentum Stock Ideas - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Published on: 2025-10-26 15:06:18 - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Leading vs lagging indicators on RAPT Therapeutics Inc. performanceInsider Selling & Technical Entry and Exit Tips - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Published on: 2025-10-26 10:44:52 - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Wells Fargo Boosts RAPT Therapeutics (RAPT) PT to $48 on Promising Anti-IgE Drug Data - Insider Monkey

Oct 26, 2025
pulisher
Oct 26, 2025

Published on: 2025-10-26 00:53:27 - newser.com

Oct 26, 2025

Rapt Therapeutics Inc Stock (RAPT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.26
price up icon 1.11%
$91.28
price up icon 2.21%
$29.89
price up icon 0.07%
$105.66
price up icon 0.87%
$159.66
price down icon 0.29%
biotechnology ONC
$310.81
price up icon 0.25%
Cap:     |  Volume (24h):